N/A
N=120
Study of Anaesthesia Costs and Recovery Profiles
Anaesthesia
Bottom Line
View on ClinicalTrials.gov: NCT02920749 ↗Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcome: Primary: Drug Consumption — 0.0983; 0.1033; 0.0991; 0.0992 mg — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Sevoflurane group A (Drug); Sevoflurane group B (Drug); Propofol group C (Drug); Propofol group D (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Pecs
- Primary completion
- Oct 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Drug Consumption |
0.0983; 0.1033; 0.0991; 0.0992; 196.3; 166.4 | <0.05 sig |
| SECONDARY Costs of Anaesthesia |
8.84; 7.86; 8.33; 7.52; 6.49; 23.25 | <0.05 sig |
Summary
The purpose of this study is to compare the perioperative hemodynamic parameters, recovery profiles and cost containment of sevoflurane and propofol based general anesthesia for otorhinolaryngeal surgery.
Eligibility Criteria
Inclusion Criteria
- ASA physical status grade I or II who were scheduled for elective otorhinolaryngological surgery.
Exclusion Criteria
- Individuals with a history of bronchial asthma, chronic obstructive pulmonary disease, epilepsy, psychiatric illness, cerebrovascular or congenital neuromuscular disease.
Data sourced from ClinicalTrials.gov (NCT02920749). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.